Electrophysiological deterioration over time in patients with Huntington's disease

Movement Disorders

Volumn 21, Issue 9, 2006, Pages 1350-1354

  Lefaucheur, Jean Pascal ^a,b   Menard Lefaucheur, Isabel ^a   Maison, Patrick ^a,b   Baudic, Sophie ^b   Cesaro, Pierre ^a,b   Peschanski, Marc ^b   Bachoud Lévi, Anne Catherine ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Assessment program; Blink reflex; Cortical silent period; Huntington's disease; Long latency reflex; Longitudinal study; Somatosensory evoked potentials; Transcranial magnetic stimulation

Indexed keywords

ADULT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE COURSE; DISEASE MARKER; EVOKED SOMATOSENSORY RESPONSE; EYELID REFLEX; FEMALE; HUMAN; HUNTINGTON CHOREA; LATENT PERIOD; MALE; NERVE STIMULATION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SYMPATHETIC TONE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33750285951     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20966     Document Type: Article

References (32)

1. Nance MA. Huntington disease: clinical, genetic, and social aspects. J Geriatr Psychiatry Neurol 1998; 11:61-70.
2. Siesling S, van Vugt JP, Zwinderman KA, Kieburtz K, Roos RA. Unified Huntington's disease rating scale: a follow up. Mov Disord 1998; 13:915-919.
3. Marder K, Zhao H, Myers RH, et al. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 2000; 54:452-458.
4. Bachoud-Lévi AC, Maison P, Bartolomeo P, et al. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology 2001;56:1052-1058.
5. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
6. Quinn Q, Brown R, Craufurd D, et al. Core Assessement Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-RD). Mov Disord 1996;11:143-150.
7. Berardelli A, Noth J, Thompson PD, et al. Pathophysiology of chorea and bradykinesia in Huntington's disease. Mov Disord 1999;14:398-403.
8. Lefaucheur JP, Bachoud-Levi AC, Bourdet C, et al. Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease. Mov Disord 2002;17:1294-1301.
9. Shoulson I. HD functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981;31:1333-1335.
10. Hoeldtke RD, Davis KM, Hsieh PB, Gaspar SR, Dworkin GE. Autonomic surface potential analysis: assessment of reproducibility and sensitivity. Muscle Nerve 1992;15:926-931.
11. Ehle AL, Stewart RM, Lellelid NA, Leventhal NA. Evoked potentials in Huntington's disease. A comparative and longitudinal study. Arch Neurol 1984;41:379-382.
12. Upton ARM, McComas AJ, Sica REP. Potentiation of "late" responses evoked in muscles during effort. J Neurol Neurosurg Psychiatry 1971;34:699-711.
13. Noth J, Podoll K, Friedemarm HH. Long-loop reflexes in small hand muscles studied in normal subjects and in patients with Huntington's disease. Brain 1985;108:65-80.
14. Deuschl G, Lücking CH, Schenck E. Hand muscle reflexes following electrical stimulation in choreatic movement disorders. J Neurol Neurosurg Psychiatry 1989;52:755-762.
15. Agostino R, Berardelli A, Cruccu G, et al. Correlation between facial involuntary movements and abnormalities of blink and corneal reflexes in Huntington's chorea. Mov Disord 1988;3:281-289.
16. Priori A, Berardelli A, Inghilleri M, Polidori L, Manfredi M. Electrornyographic silent period after transcranial brain stimulation in Huntington's disease. Mov Disord 1994;9:178-182.
17. Tegenthoff M, Vorgerd M, Juskowiak F, Roos V, Malin JP. Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease. Electroencephogr Clin Neurophysiol 1996;101:298-303.
18. Beenen N, Buttner U, Lange HW. The diagnostic value of eye movement recordings in patients with Huntington's disease and their offspring. Electroencephalogr Clin Neurophysiol 1986;63: 119-127.
19. Noth J, Engel L, Friedemann HH, Lange HW. Evoked potentials in patients with Huntington's disease and their offspring. I. Somatosensory evoked potentials. Electroencephogr Clin Neurophysiol 1984;59:134-141.
20. Kuwert T, Noth J, Scholz D, et al. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Mov Disord 1993;8:98-106.
21. Peschanski M, Cesaro P, Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995;68:273-285.
22. Schwarz M, Block F, Töpper R, Sontag KH, Noth J. Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease: evidence that basal ganglia modulate sensory cortical input. Ann Neurol 1992;32:358-364.
23. Block F, Schwarz M, Sontag KH. Non-NMDA mediated transmission of somatosensory evoked potentials in the rat thalamus. Brain Res Bull 1993;31:449-454.
24. Basso MA, Powers AS, Evinger C. An explanation for reflex blink hyperexcitability in Parkinson's disease. I. Superior colliculus. J Neurosci 1996;16:7308-7317.
25. Basso MA, Evinger C. An explanation for reflex blink hyperexcitability in Parkinson's disease. H. Nucleus raphe magnus. J Neurosci 1996;16:7318-7330.
26. Esteban A, Mateo D, Gimenez-Roldan S. Early detection of Huntington's disease. Blink reflex and levodopa load in presymptomatic and incipient subjects. J Neurol Neurosurg Psychiatry 1981; 44:43-48.
27. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol (Lond) 1999;517:591-597.
28. Thompson PD, Berardelli A, Rothwell JC, et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 1988;111:223-244.
29. Storey E, Beal MF. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain 1993; 116:1201-1222.
30. Bachoud-Lévi AC, Rémy P, Nguyen JP, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000;356:1975-1979.
31. Bachoud-Lévi AC, Hantraye P, Peschanski M. Fetal neural grafts for Huntington's disease: a prospective view. Mov Disord 2002; 17:439-444.
32. Bloch J, Bachoud-Lévi AC, Déglon N, et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum Gene Ther 2004;15:968-975.